GlassScriptPhysician profile
Jeffrey A Miller
NPI 1508905704
$33,361.33
in general payments reported to CMS, 2019-2025
31 companies · $3,365 in 2025
The $3,365 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,462 · 2020: $5,320 · 2021: $5,320 · 2022: $4,360 · 2023: $12K · 2024: $1,403 · 2025: $3,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,800 · Food and Beverage: $7,530 · Travel and Lodging: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,800.00 |
| Food and Beverage | $7,529.61 |
| Travel and Lodging | $1,569.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21,073.38 | 2021-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Inceptiv |
| Medtronic USA, INC. | $5,036.45 | 2019-2020 | |
| Abbott Laboratories | $1,551.32 | 2019-2023 | Proclaim |
| Forte Bio-Pharma LLC | $1,104.25 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Becton, Dickinson and Company | $850.00 | 2019 | |
| Saluda Medical Americas, INC. | $682.07 | 2024-2025 | Evoke |
| Abbvie INC. | $537.64 | 2021-2024 | |
| Boston Scientific Corporation | $337.05 | 2019-2024 | |
| Nevro Corp. | $315.56 | 2023-2024 | Senza |
| Globus Medical, INC. | $267.03 | 2025 | Senza |
| Spinal Simplicity, LLC | $230.16 | 2021-2024 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $188.96 | 2022-2025 | Belbuca, Xtampza |
| Si-Bone, INC. | $151.14 | 2023-2025 | |
| Amgen INC. | $142.36 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.02 | 2024-2025 | Relistor |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $79.84 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $79.68 | 2022 | |
| Lilly USA, LLC | $77.08 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $75.63 | 2024-2025 | |
| Allergan, INC. | $75.00 | 2020-2022 | |
| Spr Therapeutics, INC | $70.48 | 2022-2025 | Sprint Pns System |
| Teva Pharmaceuticals USA, INC. | $49.19 | 2019 | |
| Biodelivery Sciences International, INC. | $46.21 | 2021 | |
| Nalu Medical, INC. | $41.90 | 2020-2024 | Nalu Neurostimulation System |
| Zimmer Biomet Holdings, INC. | $40.65 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Scilex Pharmaceuticals INC. | $29.32 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $25.00 | 2025 | Iovera, Zilretta |
| Grt US Holding, INC. | $20.42 | 2022 | |
| Tonix Medicines, INC. | $19.89 | 2025 | Tonmya |
| Stimwave Technologies Incorporated | $16.96 | 2021 | |
| Lundbeck LLC | $15.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.